Somerset, Aug 09, 2022 -- WhizAI has announced a strategic partnership with Conexus Solutions, Inc., a leader in providing small and mid-size life sciences companies with sales and marketing operations support. The partnership brings together WhizAI, the only AI-powered analytics platform purpose-built for life sciences and healthcare, and Conexus’ team of life science industry veterans and technology experts who have a passion for solving operational challenges in the life sciences industry.
As a result of this collaboration, small and mid-size life sciences companies will be able to make insights driven commercial teams a reality. Many of the small and mid-size pharma companies lack sufficient IT and data science resources in their organization to support the field with analytics insights. Now with WhizAI and Conexus together, these companies can have the same prowess that large pharma levegages with the right systems, tools, and processes in place for better, faster, and smarter decisions at lower cost.
“Going to market with Conexus produces an all-encompassing partnership, giving our clients an analytics ecosystem that ensures navigating insights has never been easier," said Rohit Vashisht, Co-Founder and Chief Executive Officer of WhizAI. “Both companies understand the challenges small to medium sized pharma faces with lack of IT resources, growing complexity of data, and a complex technology landscape to understand data and actionable insights. This partnership helps pharma organizations' sales and marketing teams maximize their effectiveness.”
“The demands sales and marketing leaders face in small to mid-size pharma keeps growing," said Akshay Kapadia, Chief Executive Officer at Conexus. “Providing our clients with an end-to-end ecosystem purpose built for their needs, our turnkey solutions to improve operations and streamline workflows, plus a powerful and intuitive analytics platform will improve overall efficiency in the insights process and enable our clients to maximize the success of their business.”
About WhizAI: WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences domain and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences making WhizAI the trusted partner of choice at top global life sciences companies. Learn more at whiz.ai.
About Conexus Solutions, Inc.: Conexus Solutions, Inc. provides small and mid-size life sciences companies with sales and marketing operations support. This includes implementation and ongoing support of Veeva CRM, Veeva Vault, Salesforce Sales, Service, Marketing, and Health cloud, content creation (CLM, approved email, etc.), data science and insights, a multi-level help desk and hardware depot support. Learn more at cnxsi.com.
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with Augmented Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.